This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Williams, A. F Articles by Moffatt, C. J Search for Related Content PubMed PubMed Citation Articles by Williams, A. F Articles by Moffatt, C. J Social Bookmarking                   What's this?

Lymphoedema: estimating the size of the problem

Centre for Research and Implementation of Clinical Practice, Thames Valley University, London and University of Glasgow, Glasgow

Peter J Franks

Centre for Research and Implementation of Clinical Practice, Thames Valley University, London

Christine J Moffatt

Centre for Research and Implementation of Clinical Practice, Thames Valley University, London

Lymphoedema is a problem frequently encountered by professionals working in palliative care. This article reviews the evidence on the magnitude of the problem of lymphoedema in the general population and provides evidence on specific high risk groups within it. Prevalence is a good indicator of the burden of disease for chronic problems such as lymphoedema, as it indicates the numbers of patients who require care. Incidence is indicative of changes in the causes of lymphoedema and the success of any prevention programmes. Both are important means of assessing the current level of need and the potential for the changing needs in managing this condition. Problems exist in all studies in relation to precise definitions of lymphoedema, inconsistent measures to assess differential diagnosis and poorly defined populations. While there is some evidence of high rates in relation to breast cancer therapy, the total burden of lymphoedema in the general population is largely unknown.

Key Words: chronic oedema • epidemiology • prevalence • Lymphoedema • incidence

Palliative Medicine, Vol. 19, No. 4, 300-313 (2005)
DOI: 10.1191/0269216305pm1020oa


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				Y.-C. T. Shih, Y. Xu, J. N. Cormier, S. Giordano, S. H. Ridner, T. A. Buchholz, G. H. Perkins, and L. S. Elting Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study J. Clin. Oncol., April 20, 2009; 27(12): 2007 - 2014. [Abstract] [Full Text] [PDF]

				S. A. Norman, A. R. Localio, S. L. Potashnik, H. A. Simoes Torpey, M. J. Kallan, A. L. Weber, L. T. Miller, A. DeMichele, and L. J. Solin Lymphedema in Breast Cancer Survivors: Incidence, Degree, Time Course, Treatment, and Symptoms J. Clin. Oncol., January 20, 2009; 27(3): 390 - 397. [Abstract] [Full Text] [PDF]

				C. Conrad, H. Niess, R. Huss, S. Huber, I. von Luettichau, P. J. Nelson, H. C. Ott, K.-W. Jauch, and C. J. Bruns Multipotent Mesenchymal Stem Cells Acquire a Lymphendothelial Phenotype and Enhance Lymphatic Regeneration In Vivo Circulation, January 20, 2009; 119(2): 281 - 289. [Abstract] [Full Text] [PDF]

				S. C. Hayes, M. Janda, B. Cornish, D. Battistutta, and B. Newman Lymphedema After Breast Cancer: Incidence, Risk Factors, and Effect on Upper Body Function J. Clin. Oncol., July 20, 2008; 26(21): 3536 - 3542. [Abstract] [Full Text] [PDF]

				C. Hadamitzky and R. Pabst Acquired Lymphedema: An Urgent Need for Adequate Animal Models Cancer Res., January 15, 2008; 68(2): 343 - 345. [Abstract] [Full Text] [PDF]

				L. K. Bogan, J. M. Powell, and B. J. Dudgeon Experiences of Living With Non-Cancer-Related Lymphedema: Implications for Clinical Practice Qual Health Res, February 1, 2007; 17(2): 213 - 224. [Abstract] [PDF]